Vermillion Wealth Management’s Bio-Techne TECH Stock Holding History

Vermillion Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6	Closed	-$314	–	2356
2026 Q1	$314	Buy	+6	New	+$360	﹤0.01%	1166

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vermillion Wealth Management's TECH Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 6 shares — an estimated $314 sold.

Vermillion Wealth Management first reported a position in TECH in Q1 2026 and held it in 1 quarter. The position peaked at $314 in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Vermillion Wealth Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Vermillion Wealth Management sold 6 Bio-Techne shares in Q2 2026, an estimated $314.
Vermillion Wealth Management first reported a position in Bio-Techne in Q1 2026 and held it in 1 quarter.
Vermillion Wealth Management's Bio-Techne position peaked at $314 in Q1 2026.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.